{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:37:36Z","timestamp":1789821456510,"version":"4.0.1"},"reference-count":174,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jpba.2018.12.040","type":"journal-article","created":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T17:28:48Z","timestamp":1546104528000},"page":"40-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"special_numbering":"C","title":["LC-MS application for therapeutic drug monitoring in alternative matrices"],"prefix":"10.1016","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4102-5218","authenticated-orcid":false,"given":"Valeria","family":"Avataneo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1321-4126","authenticated-orcid":false,"given":"Antonio","family":"D\u2019Avolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Cusato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cant\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5973-9948","authenticated-orcid":false,"given":"Amedeo","family":"De Nicol\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jpba.2018.12.040_bib0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2217\/pgs-2017-0123","article-title":"Precision medicine for HIV: where are we?","volume":"19","author":"Cusato","year":"2017","journal-title":"Pharmacogenomics"},{"issue":"Suppl. 1","key":"10.1016\/j.jpba.2018.12.040_bib0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00228-013-1504-x","article-title":"Therapeutic drug monitoring for tomorrow","volume":"69","author":"Eliasson","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.jpba.2018.12.040_bib0015","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jac\/dkt508","article-title":"Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology","volume":"69","author":"Ashbee","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"issue":"8","key":"10.1016\/j.jpba.2018.12.040_bib0020","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1517\/14712598.2015.1044434","article-title":"Therapeutic drug monitoring of anti-TNF-alpha agents in inflammatory bowel diseases","volume":"15","author":"Felice","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"issue":"9","key":"10.1016\/j.jpba.2018.12.040_bib0025","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1097\/MIB.0000000000000420","article-title":"The role of therapeutic drug monitoring of anti-tumor necrosis factor alpha agents in children and adolescents with inflammatory bowel disease","volume":"21","author":"Joosse","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"issue":"4","key":"10.1016\/j.jpba.2018.12.040_bib0030","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s11894-014-0378-0","article-title":"Therapeutic drug monitoring in inflammatory bowel disease: current state and future perspectives","volume":"16","author":"Vande Casteele","year":"2014","journal-title":"Curr. Gastroenterol. Rep."},{"issue":"2","key":"10.1016\/j.jpba.2018.12.040_bib0035","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00467-014-2813-8","article-title":"Therapeutic drug monitoring in pediatric renal transplantation","volume":"30","author":"Weber","year":"2014","journal-title":"Pediatr. Nephrol."},{"issue":"12","key":"10.1016\/j.jpba.2018.12.040_bib0040","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.ejca.2014.04.015","article-title":"Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapies","volume":"50","author":"Widmer","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.jpba.2018.12.040_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099044","article-title":"Guidelines for therapeutic drug monitoring of vancomycin: a systematic review","volume":"9","author":"Ye","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2018.12.040_bib0050","first-page":"33","article-title":"Therapeutic drug monitoring and LC-MS\/MS","volume":"883\u2013884","author":"Adaway","year":"2011","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2018.12.040_bib0055","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.trac.2017.10.002","article-title":"Beyond dried blood spot: current microsampling techniques in the context of biomedical applications","volume":"97","author":"Nys","year":"2017","journal-title":"Trac Trends Anal. Chem."},{"issue":"14","key":"10.1016\/j.jpba.2018.12.040_bib0060","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.4155\/bio.11.132","article-title":"EBF recommendation on the validation of bioanalytical methods for dried blood spots","volume":"3","author":"Timmerman","year":"2011","journal-title":"Bioanalysis"},{"issue":"17","key":"10.1016\/j.jpba.2018.12.040_bib0065","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.4155\/bio.13.173","article-title":"Update of the EBF recommendation for the use of DBS in regulated bioanalysis integrating the conclusions from the EBF DBS-microsampling consortium","volume":"5","author":"Timmerman","year":"2013","journal-title":"Bioanalysis"},{"issue":"3","key":"10.1016\/j.jpba.2018.12.040_bib0070","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/FTD.0b013e31819e91ce","article-title":"Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls","volume":"31","author":"Edelbroek","year":"2009","journal-title":"Ther. Drug Monit."},{"issue":"17","key":"10.1016\/j.jpba.2018.12.040_bib0075","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.4155\/bio.13.175","article-title":"State-of-the-art dried blood spot analysis: an overview of recent advances and future trends","volume":"5","author":"Meesters","year":"2013","journal-title":"Bioanalysis"},{"issue":"13\u201314","key":"10.1016\/j.jpba.2018.12.040_bib0080","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.clinbiochem.2016.05.004","article-title":"Dried blood spots analysis with mass spectrometry: potentials and pitfalls in therapeutic drug monitoring","volume":"49","author":"Antunes","year":"2016","journal-title":"Clin. Biochem."},{"issue":"11","key":"10.1016\/j.jpba.2018.12.040_bib0085","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s40262-014-0177-7","article-title":"Therapeutic drug monitoring by dried blood spot: progress to date and future directions","volume":"53","author":"Wilhelm","year":"2014","journal-title":"Clin. Pharmacokinet."},{"issue":"11","key":"10.1016\/j.jpba.2018.12.040_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143421","article-title":"A new method to quantify ifosfamide blood levels using dried blood spots and UPLC-MS\/MS in paediatric patients with embryonic solid tumours","volume":"10","author":"Torres","year":"2015","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.jpba.2018.12.040_bib0095","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.4155\/bio.15.99","article-title":"A LC-MS\/MS method for therapeutic drug monitoring of carbamazepine, lamotrigine and valproic acid in DBS","volume":"7","author":"Linder","year":"2015","journal-title":"Bioanalysis"},{"issue":"3","key":"10.1016\/j.jpba.2018.12.040_bib0100","doi-asserted-by":"crossref","DOI":"10.19080\/CTBEB.2018.14.555886","article-title":"Dried blood spot for developing countries: an opinion","volume":"14","author":"Saud","year":"2018","journal-title":"Curr. Trends Biomed. Eng. Biosci."},{"issue":"9","key":"10.1016\/j.jpba.2018.12.040_bib0105","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S1473-3099(15)00226-1","article-title":"Dried blood spot for Ebola testing in developing countries","volume":"15","author":"Sarkar","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jpba.2018.12.040_bib0110","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cca.2013.02.009","article-title":"Clinical validation and implementation of a multiplexed immunosuppressant assay in dried blood spots by LC-MS\/MS","volume":"421","author":"Sadilkova","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jpba.2018.12.040_bib0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.talanta.2013.04.027","article-title":"Fast LC-MS\/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery","volume":"115","author":"Koster","year":"2013","journal-title":"Talanta"},{"issue":"9-10","key":"10.1016\/j.jpba.2018.12.040_bib0120","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1007\/s00216-014-7619-9","article-title":"Determination of venlafaxine and O-desmethylvenlafaxine in dried blood spots for TDM purposes, using LC-MS\/MS","volume":"406","author":"Berm","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2018.12.040_bib0125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.talanta.2014.10.041","article-title":"A simple dried blood spot method for therapeutic drug monitoring of the tricyclic antidepressants amitriptyline, nortriptyline, imipramine, clomipramine, and their active metabolites using LC-MS\/MS","volume":"134","author":"Berm","year":"2015","journal-title":"Talanta"},{"issue":"15","key":"10.1016\/j.jpba.2018.12.040_bib0130","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.4155\/bio.15.123","article-title":"Current advances in biosampling for therapeutic drug monitoring of psychiatric CNS drugs","volume":"7","author":"Mercolini","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2018.12.040_bib0135","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jpba.2015.02.045","article-title":"Therapeutic drug monitoring of carbamazepine and its metabolite in children from dried blood spots using liquid chromatography and tandem mass spectrometry","volume":"109","author":"Shokry","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.12.040_bib0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cca.2014.11.007","article-title":"Dried blood spot assay for the quantification of phenytoin using Liquid Chromatography-Mass Spectrometry","volume":"440","author":"Villanelli","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"10","key":"10.1016\/j.jpba.2018.12.040_bib0145","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1128\/AAC.00707-13","article-title":"Dried blood spot analysis suitable for therapeutic drug monitoring of voriconazole, fluconazole, and posaconazole","volume":"57","author":"van der Elst","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2018.12.040_bib0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.talanta.2013.12.043","article-title":"Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC-MS\/MS","volume":"121","author":"Vu","year":"2014","journal-title":"Talanta"},{"issue":"1","key":"10.1016\/j.jpba.2018.12.040_bib0155","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/AAC.01740-15","article-title":"Validation and application of a dried blood spot ceftriaxone assay","volume":"60","author":"Page-Sharp","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2018.12.040_bib0160","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jpba.2013.08.033","article-title":"Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS\/MS","volume":"88","author":"Zheng","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.jpba.2018.12.040_bib0165","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/FTD.0000000000000127","article-title":"A validated method for quantification of efavirenz in dried blood spots using high-performance liquid chromatography-mass spectrometry","volume":"37","author":"Amara","year":"2015","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2018.12.040_bib0170","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.talanta.2014.10.040","volume":"132","author":"Antunes","year":"2015","journal-title":"Talanta"},{"issue":"16","key":"10.1016\/j.jpba.2018.12.040_bib0175","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.4155\/bio.15.101","article-title":"DBS sampling in imatinib therapeutic drug monitoring: from method development to clinical application","volume":"7","author":"Antunes","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2018.12.040_bib0180","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jpba.2017.04.045","article-title":"Quantitative LC-HRMS determination of selected cardiovascular drugs, in dried blood spots, as an indicator of adherence to medication","volume":"142","author":"Bernieh","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.jpba.2018.12.040_bib0185","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/FTD.0000000000000502","article-title":"Dried blood spot analysis for therapeutic drug monitoring of antipsychotics: drawbacks of its clinical application","volume":"40","author":"Kloosterboer","year":"2018","journal-title":"Ther. Drug Monit."},{"issue":"11","key":"10.1016\/j.jpba.2018.12.040_bib0190","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.4155\/bio.10.159","article-title":"Pharmacokinetic considerations as to when to use dried blood spot sampling","volume":"2","author":"Emmons","year":"2010","journal-title":"Bioanalysis"},{"issue":"8","key":"10.1016\/j.jpba.2018.12.040_bib0195","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.4155\/bio.10.103","article-title":"The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs","volume":"2","author":"Denniff","year":"2010","journal-title":"Bioanalysis"},{"issue":"20","key":"10.1016\/j.jpba.2018.12.040_bib0200","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.4155\/bio.11.220","article-title":"The effect of hematocrit and punch location on assay bias during quantitative bioanalysis of dried blood spot samples","volume":"3","author":"O\u2019Mara","year":"2011","journal-title":"Bioanalysis"},{"issue":"16","key":"10.1016\/j.jpba.2018.12.040_bib0205","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.4155\/bio.12.175","article-title":"Dried matrix on paper disks: the next generation DBS microsampling technique for managing the hematocrit effect in DBS analysis","volume":"4","author":"Meesters","year":"2012","journal-title":"Bioanalysis"},{"issue":"19","key":"10.1016\/j.jpba.2018.12.040_bib0210","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1002\/rcm.5182","article-title":"Pre-cut dried blood spot (PCDBS): an alternative to dried blood spot (DBS) technique to overcome hematocrit impact","volume":"25","author":"Youhnovski","year":"2011","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"5","key":"10.1016\/j.jpba.2018.12.040_bib0215","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/jms.3015","article-title":"Perforated dried blood spot accurate microsampling: the concept and its applications in toxicokinetic sample collection","volume":"47","author":"Li","year":"2012","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.jpba.2018.12.040_bib0220","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jpba.2012.04.007","article-title":"Rapid and sensitive LC-MS\/MS method for the analysis of antibiotic linezolid on dried blood spot","volume":"67\u201368","author":"la Marca","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.12.040_bib0225","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jpba.2013.01.034","article-title":"A rapid liquid chromatography tandem mass spectrometry-based method for measuring propranolol on dried blood spots","volume":"78\u201379","author":"Della Bona","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"26","key":"10.1016\/j.jpba.2018.12.040_bib0230","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.1007\/s00216-014-8114-z","article-title":"Potassium-based algorithm allows correction for the hematocrit bias in quantitative analysis of caffeine and its major metabolite in dried blood spots","volume":"406","author":"De Kesel","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"issue":"4","key":"10.1016\/j.jpba.2018.12.040_bib0235","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1021\/ac503931g","article-title":"New microfluidic-based sampling procedure for overcoming the hematocrit problem associated with dried blood spot analysis","volume":"87","author":"Leuthold","year":"2015","journal-title":"Anal. Chem."},{"issue":"9","key":"10.1016\/j.jpba.2018.12.040_bib0240","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4155\/bio.13.58","article-title":"A novel approach to capillary plasma microsampling for quantitative bioanalysis","volume":"5","author":"Bowen","year":"2013","journal-title":"Bioanalysis"},{"issue":"3","key":"10.1016\/j.jpba.2018.12.040_bib0245","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4155\/bio.13.286","article-title":"Blood microsampling using capillaries for drug-exposure determination in early preclinical studies: a beneficial strategy to reduce blood sample volumes","volume":"6","author":"Dillen","year":"2014","journal-title":"Bioanalysis"},{"issue":"4","key":"10.1016\/j.jpba.2018.12.040_bib0250","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4155\/bio.14.275","article-title":"Capillary microsampling of whole blood for mouse PK studies: an easy route to serial blood sampling","volume":"7","author":"Korfmacher","year":"2015","journal-title":"Bioanalysis"},{"issue":"5","key":"10.1016\/j.jpba.2018.12.040_bib0255","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jpba.2010.02.026","article-title":"HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions","volume":"52","author":"D\u2019Avolio","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"5","key":"10.1016\/j.jpba.2018.12.040_bib0260","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/bcp.12544","article-title":"Dried plasma\/blood spots for monitoring antiretroviral treatment efficacy and pharmacokinetics: a cross-sectional study in rural Burundi","volume":"79","author":"Calcagno","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2018.12.040_bib0265","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jpba.2018.01.043","article-title":"Determination of oxycodone and its major metabolites in haematic and urinary matrices: comparison of traditional and miniaturised sampling approaches","volume":"152","author":"Protti","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"16","key":"10.1016\/j.jpba.2018.12.040_bib0270","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.4155\/bio.15.98","article-title":"Novel membrane devices and their potential utility in blood sample collection prior to analysis of dried plasma spots","volume":"7","author":"Sturm","year":"2015","journal-title":"Bioanalysis"},{"issue":"17","key":"10.1016\/j.jpba.2018.12.040_bib0275","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.1021\/acs.analchem.6b02199","article-title":"Procedures for analysis of dried plasma using microsampling devices to detect sulfur mustard-albumin adducts for verification of poisoning","volume":"88","author":"John","year":"2016","journal-title":"Anal. Chem."},{"issue":"16","key":"10.1016\/j.jpba.2018.12.040_bib0280","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1021\/ac5022562","article-title":"Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis","volume":"86","author":"Denniff","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2018.12.040_bib0285","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jpba.2017.07.029","article-title":"Volumetric absorptive microsampling: current advances and applications","volume":"147","author":"Kok","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.12.040_bib0290","unstructured":"neoteryx \u00ae The promise of microsampling, delivered. https:\/\/www.neoteryx.com\/, (Accessed 16 July 2018)."},{"issue":"19","key":"10.1016\/j.jpba.2018.12.040_bib0295","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.4155\/bio.15.173","article-title":"Quantitative bioanalytical validation of fosfomycin in human whole blood with volumetric absorptive microsampling","volume":"7","author":"Parker","year":"2015","journal-title":"Bioanalysis"},{"issue":"4","key":"10.1016\/j.jpba.2018.12.040_bib0300","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4155\/bio-2015-0028","article-title":"Evaluation of sample extraction methods for minimizing hematocrit effect on whole blood analysis with volumetric absorptive microsampling","volume":"9","author":"Ye","year":"2017","journal-title":"Bioanalysis"},{"issue":"6","key":"10.1016\/j.jpba.2018.12.040_bib0305","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4155\/bio.14.310","article-title":"A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocrit","volume":"7","author":"Spooner","year":"2015","journal-title":"Bioanalysis"},{"issue":"15","key":"10.1016\/j.jpba.2018.12.040_bib0310","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.4155\/bio.15.111","article-title":"Hematocrit-independent recovery is a key for bioanalysis using volumetric absorptive microsampling devices, Mitra","volume":"7","author":"Mano","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2018.12.040_bib0315","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jpba.2017.07.033","article-title":"Volumetric adsorptive microsampling-liquid chromatography tandem mass spectrometry assay for the simultaneous quantification of four antibiotics in human blood: method development, validation and comparison with dried blood spot","volume":"145","author":"Barco","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"9","key":"10.1016\/j.jpba.2018.12.040_bib0320","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1007\/s00216-018-0866-4","article-title":"Volumetric absorptive microsampling as an alternative tool for therapeutic drug monitoring of first-generation anti-epileptic drugs","volume":"410","author":"Velghe","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2018.12.040_bib0325","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jpba.2017.05.050","article-title":"Application of volumetric absorptive microsampling device for quantification of tacrolimus in human blood as a model drug of high blood cell partition","volume":"143","author":"Kita","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.12.040_bib0330","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jpba.2016.12.012","article-title":"Volumetric absorptive microsampling (VAMS) as an alternative to conventional dried blood spots in the quantification of miltefosine in dried blood samples","volume":"135","author":"Kip","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"12","key":"10.1016\/j.jpba.2018.12.040_bib0335","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1373\/clinchem.2016.263715","article-title":"Stable-isotope dilution HPLC-Electrospray ionization tandem mass spectrometry method for quantifying hydroxyurea in dried blood samples","volume":"62","author":"Marahatta","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2018.12.040_bib0340","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jpba.2017.03.047","article-title":"Capillary blood collected on volumetric absorptive microsampling (VAMS) device for monitoring hydroxychloroquine in rheumatoid arthritis patients","volume":"140","author":"Qu","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.jpba.2018.12.040_bib0345","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/dta.2255","article-title":"Power of Orbitrap-based LC-high resolution-MS\/MS for comprehensive drug testing in urine with or without conjugate cleavage or using dried urine spots after on-spot cleavage in comparison to established LC-MS(n) or GC-MS procedures","volume":"10","author":"Michely","year":"2017","journal-title":"Drug Test. Anal."},{"issue":"21","key":"10.1016\/j.jpba.2018.12.040_bib0350","doi-asserted-by":"crossref","first-page":"11779","DOI":"10.1021\/acs.analchem.7b03398","article-title":"Paper spray ionization coupled to high resolution tandem mass spectrometry for comprehensive urine drug testing in comparison to liquid chromatography-coupled techniques after urine precipitation or dried urine spot workup","volume":"89","author":"Michely","year":"2017","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2018.12.040_bib0355","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.forsciint.2017.11.006","article-title":"Simultaneous drug identification in urine of sexual assault victims by using liquid chromatography tandem mass spectrometry","volume":"282","author":"Lee","year":"2017","journal-title":"Forensic Sci. Int."},{"issue":"4","key":"10.1016\/j.jpba.2018.12.040_bib0360","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/FTD.0000000000000417","article-title":"Challenges for detecting valproic acid in a nontargeted urine drug screening method","volume":"39","author":"Pope","year":"2017","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2018.12.040_bib0365","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cca.2018.02.034","article-title":"Monitoring opioid and benzodiazepine use and abuse: Is oral fluid or urine the preferred specimen type?","volume":"481","author":"Petrides","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jpba.2018.12.040_bib0370","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jpba.2017.05.018","article-title":"UHPLC-MS\/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples","volume":"142","author":"De Nicol\u00f2","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.jpba.2018.12.040_bib0375","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1039\/C4AN02321H","article-title":"A HPLC-SRM-MS based method for the detection and quantification of methotrexate in urine at doses used in clinical practice for patients with rheumatological disease: a potential measure of adherence","volume":"140","author":"Bluett","year":"2015","journal-title":"Analyst"},{"key":"10.1016\/j.jpba.2018.12.040_bib0380","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jpba.2015.05.001","article-title":"A LC-MS method to quantify tenofovir urinary concentrations in treated patients","volume":"114","author":"Simiele","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"7","key":"10.1016\/j.jpba.2018.12.040_bib0385","doi-asserted-by":"crossref","first-page":"E1107","DOI":"10.36076\/ppj\/2017.7.E1107","article-title":"Lower cutoffs for LC-MS\/MS urine drug testing indicates better patient compliance","volume":"20","author":"Krock","year":"2017","journal-title":"Pain Phys."},{"issue":"8","key":"10.1016\/j.jpba.2018.12.040_bib0390","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4155\/bio.15.35","article-title":"Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS\/MS","volume":"7","author":"Ghareeb","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2018.12.040_bib0395","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jchromb.2016.10.008","article-title":"Development and validation of a sensitive and selective LC-MS\/MS method for determination of tacrolimus in oral fluids","volume":"1038","author":"Ghareeb","year":"2016","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2018.12.040_bib0400","doi-asserted-by":"crossref","DOI":"10.1007\/s40262-017-0626-1","article-title":"Tacrolimus concentration in saliva of kidney transplant recipients: factors influencing the relationship with whole blood concentrations","author":"Ghareeb","year":"2018","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.jpba.2018.12.040_bib0405","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/FTD.0000000000000508","article-title":"Serum and saliva concentrations of venlafaxine, O-desmethylvenlafaxine, quetiapine, and citalopram in psychiatric patients","volume":"40","author":"Ebert","year":"2018","journal-title":"Ther. Drug Monit."},{"issue":"12","key":"10.1016\/j.jpba.2018.12.040_bib0410","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.clinthera.2015.11.002","article-title":"Saliva versus plasma for pharmacokinetic and pharmacodynamic studies of fentanyl in patients with cancer","volume":"37","author":"Bista","year":"2015","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jpba.2018.12.040_bib0415","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.talanta.2015.11.044","article-title":"Quantitative determination of the enantiomers of methadone in human plasma and saliva by chiral column chromatography coupled with mass spectrometric detection","volume":"149","author":"George","year":"2016","journal-title":"Talanta"},{"issue":"4","key":"10.1016\/j.jpba.2018.12.040_bib0420","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/FTD.0000000000000520","article-title":"Interindividual and intraindividual variation of methylphenidate concentrations in serum and saliva of patients with Attention-Deficit\/Hyperactivity disorder","volume":"40","author":"Preiskorn","year":"2018","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.jpba.2018.12.040_bib0425","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00467-010-1670-3","article-title":"Measurement of saliva tacrolimus levels in pediatric renal transplant recipients","volume":"26","author":"Belostotsky","year":"2010","journal-title":"Pediatr. Nephrol."},{"issue":"17","key":"10.1016\/j.jpba.2018.12.040_bib0430","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.4155\/bio.14.194","article-title":"Trends in drug testing in oral fluid and hair as alternative matrices","volume":"6","author":"Wille","year":"2014","journal-title":"Bioanalysis"},{"issue":"3","key":"10.1016\/j.jpba.2018.12.040_bib0435","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/FTD.0000000000000396","article-title":"Comparison of plasma, saliva, and hair levetiracetam concentrations","volume":"39","author":"Karas-Ruszczyk","year":"2017","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.jpba.2018.12.040_bib0440","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/FTD.0b013e31827c11e7","article-title":"Therapeutic drug monitoring of antiepileptic drugs by use of saliva","volume":"35","author":"Patsalos","year":"2013","journal-title":"Ther. Drug Monit."},{"issue":"9","key":"10.1016\/j.jpba.2018.12.040_bib0445","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.clinthera.2017.07.044","article-title":"Can saliva and plasma methadone concentrations be used for enantioselective pharmacokinetic and pharmacodynamic studies in patients with advanced cancer?","volume":"39","author":"George","year":"2017","journal-title":"Clin. Ther."},{"issue":"7","key":"10.1016\/j.jpba.2018.12.040_bib0450","doi-asserted-by":"crossref","first-page":"567","DOI":"10.5414\/CP202789","article-title":"Plasma and saliva concentrations of abacavir, tenofovir, darunavir, and raltegravir in HIV-1-infected patients","volume":"55","author":"Yamada","year":"2017","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.jpba.2018.12.040_bib0455","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/COH.0b013e32835fc68a","article-title":"Overcoming pharmacologic sanctuaries","volume":"8","author":"Cory","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.jpba.2018.12.040_bib0460","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.talanta.2016.12.052","article-title":"Utilizing online-dual-SPE-LC with HRMS for the simultaneous quantification of amphotericin B, fluconazole, and fluorocytosine in human plasma and cerebrospinal fluid","volume":"165","author":"Qu","year":"2016","journal-title":"Talanta"},{"issue":"8","key":"10.1016\/j.jpba.2018.12.040_bib0465","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.3939","article-title":"A UPLC-MS\/MS method for analysis of vancomycin in human cerebrospinal fluid and comparison with the chemiluminescence immunoassay","volume":"31","author":"Mei","year":"2017","journal-title":"Biomed. Chromatogr."},{"issue":"2","key":"10.1016\/j.jpba.2018.12.040_bib0470","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijantimicag.2017.02.024","article-title":"Low penetration of caspofungin into cerebrospinal fluid following intravenous administration of standard doses","volume":"50","author":"Strenger","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jpba.2018.12.040_bib0475","article-title":"Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals","volume":"2016","author":"Nwogu","year":"2016","journal-title":"AIDS Res. Treat."},{"issue":"6","key":"10.1016\/j.jpba.2018.12.040_bib0480","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/bcp.13552","article-title":"Cerebrospinal fluid abacavir concentrations in HIV-positive patients following once-daily administration","volume":"84","author":"Calcagno","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.jpba.2018.12.040_bib0485","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/cid\/ciu976","article-title":"Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trial","volume":"60","author":"Winston","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jpba.2018.12.040_bib0490","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/cid\/ciu773","article-title":"Cerebrospinal fluid inhibitory quotients of antiretroviral drugs in HIV-infected patients are associated with compartmental viral control","volume":"60","author":"Calcagno","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jpba.2018.12.040_bib0495","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jpba.2017.02.057","article-title":"Development of an UPLC-MS\/MS method for quantification of Avitinib (AC0010) and its five metabolites in human cerebrospinal fluid: application to a study of the blood-brain barrier penetration rate of non-small cell lung cancer patients","volume":"139","author":"Wang","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.12.040_bib0500","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.forsciint.2017.01.015","article-title":"Ultra-high-performance liquid chromatography tandem mass spectrometry determination of GHB, GHB-glucuronide in plasma and cerebrospinal fluid of narcoleptic patients under sodium oxybate treatment","volume":"274","author":"Tittarelli","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2018.12.040_bib0505","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.13706","article-title":"Therapeutic drug monitoring guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence","author":"Avataneo","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2018.12.040_bib0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpba.2018.03.031","article-title":"A novel single-step GC-MS\/MS method for cannabinoids and 11-OH-THC metabolite analysis in hair","volume":"155","author":"Angeli","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1-2","key":"10.1016\/j.jpba.2018.12.040_bib0515","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.aca.2011.08.013","article-title":"Electrospray ionization tandem mass spectrometry for the simultaneous determination of opiates and cocaine in human hair","volume":"704","author":"Miguez-Framil","year":"2011","journal-title":"Anal. Chim. Acta"},{"issue":"2","key":"10.1016\/j.jpba.2018.12.040_bib0520","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/01.ftd.0000197091.07807.22","article-title":"Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use","volume":"28","author":"Musshoff","year":"2006","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2018.12.040_bib0525","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jchromb.2016.06.015","article-title":"Determination of methamphetamine enantiomer composition in human hair by non-chiral liquid chromatography-tandem mass spectrometry method","volume":"1028","author":"Shu","year":"2016","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"5","key":"10.1016\/j.jpba.2018.12.040_bib0530","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s12272-018-1013-7","article-title":"Development of a column-switching LC-MS\/MS method of tramadol and its metabolites in hair and application to a pharmacogenetic study","volume":"41","author":"Yu","year":"2018","journal-title":"Arch. Pharm. Res."},{"issue":"1-2","key":"10.1016\/j.jpba.2018.12.040_bib0535","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cca.2006.02.019","article-title":"State of the art in hair analysis for detection of drug and alcohol abuse","volume":"370","author":"Pragst","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jpba.2018.12.040_bib0540","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jpba.2012.10.023","article-title":"Simultaneous analysis of antiretroviral drugs abacavir and tenofovir in human hair by liquid chromatography-tandem mass spectrometry","volume":"74","author":"Shah","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.12.040_bib0545","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jchromb.2018.03.021","article-title":"Simultaneous determination of antiretroviral drugs in human hair with liquid chromatography-electrospray ionization-tandem mass spectrometry","volume":"1083","author":"Wu","year":"2018","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"5","key":"10.1016\/j.jpba.2018.12.040_bib0550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155887","article-title":"Quantifying isoniazid levels in small hair samples: a novel method for assessing adherence during the treatment of latent and active tuberculosis","volume":"11","author":"Gerona","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jpba.2018.12.040_bib0555","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/rcm.8058","article-title":"Development and validation of an assay to analyze atazanavir in human hair via liquid chromatography\/tandem mass spectrometry","volume":"32","author":"Phung","year":"2018","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"Suppl. 1","key":"10.1016\/j.jpba.2018.12.040_bib0560","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1097\/QAI.0b013e3180600766","article-title":"The role of adherence to antiretroviral therapy in the management of HIV infection","volume":"45","author":"Conway","year":"2007","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.jpba.2018.12.040_bib0565","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1586\/eri.13.8","article-title":"Assessing adherence to antiretroviral therapy in randomized HIV clinical trials: a review of currently used methods","volume":"11","author":"Marcellin","year":"2013","journal-title":"Expert Rev. Anti. Ther."},{"issue":"10","key":"10.1016\/j.jpba.2018.12.040_bib0570","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-139-10-200311180-00008","article-title":"Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells\/L","volume":"139","author":"Wood","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jpba.2018.12.040_bib0575","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.forsciint.2017.11.004","article-title":"Role of hair pigmentation in drug incorporation into hair","volume":"281","author":"Yu","year":"2017","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2018.12.040_bib0580","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jpba.2013.11.027","article-title":"Development and validation of a useful UPLC-MS\/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients","volume":"90","author":"Agnesod","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"9","key":"10.1016\/j.jpba.2018.12.040_bib0585","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1093\/jac\/dkv148","article-title":"A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCs","volume":"70","author":"Baietto","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.jpba.2018.12.040_bib0590","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1432-2277.2011.01365.x","article-title":"Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study","volume":"25","author":"Capron","year":"2011","journal-title":"Transpl. Int."},{"key":"10.1016\/j.jpba.2018.12.040_bib0595","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jpba.2015.08.004","article-title":"UPLC-MS\/MS method with automated on-line SPE for the isomer-specific quantification of the first-generation anti-HCV protease inhibitors in peripheral blood mononuclear cells","volume":"115","author":"De Nicol\u00f2","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.12.040_bib0600","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jpba.2014.05.040","article-title":"UPLC-MS\/MS method for quantification of the azathioprine metabolites 6-mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood mononuclear cells","volume":"98","author":"De Nicol\u00f2","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"15","key":"10.1016\/j.jpba.2018.12.040_bib0605","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.clinbiochem.2013.02.011","article-title":"Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: application to cardiac transplant recipients","volume":"46","author":"Lemaitre","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jpba.2018.12.040_bib0610","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jpba.2015.01.054","article-title":"An UPLC-MS\/MS method coupled with automated on-line SPE for quantification of tacrolimus in peripheral blood mononuclear cells","volume":"107","author":"Pensi","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.jpba.2018.12.040_bib0615","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jms.3909","article-title":"First UHPLC-MS\/MS method coupled with automated online SPE for quantification both of tacrolimus and everolimus in peripheral blood mononuclear cells and its application on samples from co-treated pediatric patients","volume":"52","author":"Pensi","year":"2017","journal-title":"J. Mass Spectrom."},{"issue":"6","key":"10.1016\/j.jpba.2018.12.040_bib0620","first-page":"401","article-title":"Plasma and intracellular pharmacokinetic-pharmacodynamic analysis of mycophenolic acid in de novo kidney transplant patients","volume":"48","author":"Thi","year":"2014","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.jpba.2018.12.040_bib0625","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/bmc.3682","article-title":"A comprehensive review of the published assays for the quantitation of the immunosuppressant drug mycophenolic acid and its glucuronidated metabolites in biological fluids","volume":"30","author":"Syed","year":"2016","journal-title":"Biomed. Chromatogr."},{"issue":"9","key":"10.1016\/j.jpba.2018.12.040_bib0630","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/bmc.3423","article-title":"Sensitive and validated LC-MS\/MS methods to evaluate mycophenolic acid pharmacokinetics and pharmacodynamics in hematopoietic stem cell transplant patients","volume":"29","author":"Kawanishi","year":"2015","journal-title":"Biomed. Chromatogr."},{"issue":"18","key":"10.1016\/j.jpba.2018.12.040_bib0635","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.clinbiochem.2013.09.009","article-title":"Mycophenolic acid quantification in human peripheral blood mononuclear cells using liquid chromatography-tandem mass spectrometry","volume":"46","author":"Nguyen Thi","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.jpba.2018.12.040_bib0640","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jpba.2015.02.051","article-title":"Development of an LC-MS\/MS assay for the quantitative determination of the intracellular 5-fluorouracil nucleotides responsible for the anticancer effect of 5-fluorouracil","volume":"110","author":"Derissen","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"7-8","key":"10.1016\/j.jpba.2018.12.040_bib0645","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.clinbiochem.2015.12.011","volume":"49","author":"Belkhir","year":"2016","journal-title":"Clin. Biochem."},{"issue":"6","key":"10.1016\/j.jpba.2018.12.040_bib0650","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/QAD.0000000000001744","article-title":"Plasma and intracellular pharmacokinetics of tenofovir in patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide","volume":"32","author":"Podany","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.jpba.2018.12.040_bib0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2018.01.005","article-title":"Establishment of intracellular tenofovir-diphosphate as the key determinant for in vitro-in vivo translation of antiviral efficacy","volume":"151","author":"Ma","year":"2018","journal-title":"Antiviral Res."},{"issue":"3","key":"10.1016\/j.jpba.2018.12.040_bib0660","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/FTD.0000000000000013","article-title":"Plasma and intracellular imatinib concentrations in patients with chronic myeloid leukemia","volume":"36","author":"De Francia","year":"2013","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2018.12.040_bib0665","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jpba.2011.10.003","article-title":"HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)","volume":"59","author":"D\u2019Avolio","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.12.040_bib0670","article-title":"Correlation between entecavir penetration in peripheral blood mononuclear cells and HBV DNA decay during treatment of HBeAg-negative chronic hepatitis B","author":"De Nicol\u00f2","year":"2017","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jpba.2018.12.040_bib0675","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jpba.2014.03.040","article-title":"Therapeutic drug monitoring of intracellular anti-infective agents","volume":"101","author":"D\u2019Avolio","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"14","key":"10.1016\/j.jpba.2018.12.040_bib0680","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.4155\/bio-2017-0059","article-title":"Matrix effect management in liquid chromatography mass spectrometry: the internal standard normalized matrix effect","volume":"9","author":"De Nicol\u00f2","year":"2017","journal-title":"Bioanalysis"},{"issue":"2","key":"10.1016\/j.jpba.2018.12.040_bib0685","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jchromb.2005.11.009","article-title":"Standard line slopes as a measure of a relative matrix effect in quantitative HPLC-MS bioanalysis","volume":"830","author":"Matuszewski","year":"2006","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2018.12.040_bib0690","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jpba.2018.03.052","article-title":"Quantitative evaluation of the matrix effect in bioanalytical methods based on LC-MS: a comparison of two approaches","volume":"155","author":"Rudzki","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.jpba.2018.12.040_bib0695","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1073\/pnas.1318249111","article-title":"Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues","volume":"111","author":"Fletcher","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7588","key":"10.1016\/j.jpba.2018.12.040_bib0700","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature16933","article-title":"Persistent HIV-1 replication maintains the tissue reservoir during therapy","volume":"530","author":"Lorenzo-Redondo","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jpba.2018.12.040_bib0705","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/FTD.0000000000000510","article-title":"Determination of tacrolimus concentration and protein expression of P-glycoprotein in single human renal core biopsies","volume":"40","author":"Krogstad","year":"2018","journal-title":"Ther. Drug Monit."},{"issue":"10","key":"10.1016\/j.jpba.2018.12.040_bib0710","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/bmc.2996","article-title":"Wahajuddin, Utility of noninvasive biomatrices in pharmacokinetic studies","volume":"27","author":"Raju","year":"2013","journal-title":"Biomed. Chromatogr."},{"issue":"1","key":"10.1016\/j.jpba.2018.12.040_bib0715","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/srt.12162","article-title":"The sweat matrix: a new perspective for drugs analysis","volume":"21","author":"Fucci","year":"2014","journal-title":"Skin Res. Technol."},{"issue":"4","key":"10.1016\/j.jpba.2018.12.040_bib0720","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00007691-199608000-00024","article-title":"Drug testing in addicts: a comparison between urine, sweat, and hair","volume":"18","author":"Kintz","year":"1996","journal-title":"Ther. Drug Monit."},{"issue":"3","key":"10.1016\/j.jpba.2018.12.040_bib0725","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/jat\/20.3.197","article-title":"Detection of codeine and phenobarbital in sweat collected with a sweat patch","volume":"20","author":"Kintz","year":"1996","journal-title":"J. Anal. Toxicol."},{"issue":"5","key":"10.1016\/j.jpba.2018.12.040_bib0730","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1520\/JFS14009J","article-title":"Sweat testing for benzodiazepines","volume":"41","author":"Kintz","year":"1996","journal-title":"J. Forensic Sci."},{"issue":"6","key":"10.1016\/j.jpba.2018.12.040_bib0735","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jat\/20.6.393","article-title":"Sweat testing in opioid users with a sweat patch","volume":"20","author":"Kintz","year":"1996","journal-title":"J. Anal. Toxicol."},{"issue":"1-2","key":"10.1016\/j.jpba.2018.12.040_bib0740","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jchromb.2007.01.037","article-title":"Determination of the volume of sweat accumulated in a sweat-patch using sodium and potassium as internal reference","volume":"852","author":"Appenzeller","year":"2007","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"3","key":"10.1016\/j.jpba.2018.12.040_bib0745","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/dta.1415","article-title":"Sweat testing for the detection of atomoxetine from paediatric patients with attention deficit\/ hyperactivity disorder: application to clinical practice","volume":"5","author":"Marchei","year":"2012","journal-title":"Drug Test. Anal."},{"issue":"4","key":"10.1016\/j.jpba.2018.12.040_bib0750","first-page":"545","article-title":"The current status of sweat testing for drugs of abuse: a review","volume":"20","author":"De Giovanni","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jpba.2018.12.040_bib0755","series-title":"Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions and Pharmacogenomics.","first-page":"279","article-title":"Alternative sampling strategies for therapeutic drug monitoring","author":"Capiau","year":"2016"},{"issue":"24","key":"10.1016\/j.jpba.2018.12.040_bib0760","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.4155\/bio-2017-0172","article-title":"Determination of olopatadine in human tears by hydrophilic interaction liquid chromatography-MS\/MS method","volume":"9","author":"Maksic","year":"2017","journal-title":"Bioanalysis"},{"issue":"8","key":"10.1016\/j.jpba.2018.12.040_bib0765","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0161-6420(81)34938-0","article-title":"Basal and reflex human tear analysis. II. Chemical analysis: lactoferrin and lysozyme","volume":"88","author":"Stuchell","year":"1981","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.jpba.2018.12.040_bib0770","first-page":"374","article-title":"The effect of collection technique on tear composition","volume":"25","author":"Stuchell","year":"1984","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.jpba.2018.12.040_bib0775","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1528-1157.1979.tb04854.x","article-title":"Tears as the best practical indicator of the unbound fraction of an anticonvulsant drug","volume":"20","author":"Monaco","year":"1979","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.jpba.2018.12.040_bib0780","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1528-1157.1981.tb04100.x","article-title":"Diphenylhydantoin and primidone in tears","volume":"22","author":"Monaco","year":"1981","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.jpba.2018.12.040_bib0785","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1528-1157.1982.tb05049.x","article-title":"The free fraction of valproic acid in tears, saliva, and cerebrospinal fluid","volume":"23","author":"Monaco","year":"1982","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.jpba.2018.12.040_bib0790","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2018.027","article-title":"Breastfeeding in patients with chronic myeloid leukaemia: case series with measurements of drug concentrations in maternal milk and literature review","volume":"10","author":"Chelysheva","year":"2018","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"Suppl. 10","key":"10.1016\/j.jpba.2018.12.040_bib0795","first-page":"S151","article-title":"Opioids in breast milk: pharmacokinetic principles and clinical implications","volume":"58","author":"Ito","year":"2018","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2018.12.040_bib0800","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.preghy.2018.01.002","article-title":"Pharmacokinetics of amlodipine besylate at delivery and during lactation","volume":"11","author":"Morgan","year":"2018","journal-title":"Pregnancy Hypertens."},{"issue":"9","key":"10.1016\/j.jpba.2018.12.040_bib0805","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002132","article-title":"Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption","volume":"13","author":"Mugwanya","year":"2016","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.jpba.2018.12.040_bib0810","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/bfm.2012.0084","article-title":"Serotonergic overstimulation in a preterm infant after sertraline intake via breastmilk","volume":"8","author":"Muller","year":"2012","journal-title":"Breastfeed. Med."},{"issue":"2","key":"10.1016\/j.jpba.2018.12.040_bib0815","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0890334414560195","article-title":"Amlodipine passage into breast milk in lactating women with pregnancy-induced hypertension and its estimation of infant risk for breastfeeding","volume":"31","author":"Naito","year":"2014","journal-title":"J. Hum. Lact."},{"issue":"4","key":"10.1016\/j.jpba.2018.12.040_bib0820","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/FTD.0000000000000300","article-title":"A liquid chromatography-tandem mass spectrometry method for quantifying amisulpride in human plasma and breast milk, applied to measuring drug transfer to a fully breast-fed neonate","volume":"38","author":"O\u2019Halloran","year":"2016","journal-title":"Ther. Drug Monit."},{"issue":"4","key":"10.1016\/j.jpba.2018.12.040_bib0825","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/jac\/dkv435","article-title":"Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the Option B-Plus approach in Malawi","volume":"71","author":"Palombi","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.jpba.2018.12.040_bib0830","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191236","article-title":"Simultaneous quantification of four antiretroviral drugs in breast milk samples from HIV-positive women by an ultra-high performance liquid chromatography tandem mass spectrometry (UPLC-MS\/MS) method","volume":"13","author":"Ramirez-Ramirez","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2018.12.040_bib0835","article-title":"Antidepressants in breast milk; comparative analysis of excretion ratios","author":"Schoretsanitis","year":"2018","journal-title":"Arch. Womens Ment. Health"},{"issue":"8","key":"10.1016\/j.jpba.2018.12.040_bib0840","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/bmc.3125","article-title":"Development and validation of a liquid chromatography\/tandem mass spectrometry method for the quantification of flucloxacillin and cloxacillin in microdialysis samples","volume":"28","author":"Larmene-Beld","year":"2014","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2018.12.040_bib0845","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpba.2018.02.005","article-title":"Sensitive analytical method to quantify clindamycin in plasma and microdialysate samples: application in a preclinical pharmacokinetic study","volume":"153","author":"Girondi","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.12.040_bib0850","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jpba.2016.10.023","article-title":"Application of a LC-MS\/MS method for evaluating lung penetration of tobramycin in rats by microdialysis","volume":"134","author":"Bernardi","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"8","key":"10.1016\/j.jpba.2018.12.040_bib0855","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/dta.2157","article-title":"Intracerebral microdialysis coupled to LC-MS\/MS for the determination tramadol and its major pharmacologically active metabolite O-desmethyltramadol in rat brain microdialysates","volume":"9","author":"Liu","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2018.12.040_bib0860","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jchromb.2012.12.027","article-title":"Determination of gemcitabine and its metabolite in extracellular fluid of rat brain tumor by ultra performance liquid chromatography-tandem mass spectrometry using microdialysis sampling after intralesional chemotherapy","volume":"919\u2013920","author":"Sun","year":"2013","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2018.12.040_bib0865","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jchromb.2015.08.022","article-title":"An LC\/MS quantitative and microdialysis method for cyclovirobuxine D pharmacokinetics in rat plasma and brain: the pharmacokinetic comparison of three different drug delivery routes","volume":"1002","author":"Wei","year":"2015","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"8","key":"10.1016\/j.jpba.2018.12.040_bib0870","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1373\/clinchem.2009.138602","article-title":"Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory","volume":"56","author":"Vogeser","year":"2010","journal-title":"Clin. Chem."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518317825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518317825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T08:54:17Z","timestamp":1760000057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708518317825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":174,"alternative-id":["S0731708518317825"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2018.12.040","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LC-MS application for therapeutic drug monitoring in alternative matrices","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2018.12.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}